WEBCOURSE I will focus on the difficulty in differential diagnosis of the diffuse symptomology of MDS and the evolving, and sometimes conflicting, classification systems for MDS.
WEBCOURSE II will detail recent progress in the development of standards of disease staging and treatment response criteria to better understand aspects of improved bone marrow function and slowed progression to acute myeloid lymphoma, as well as improved quality of life and patient survival.
WEBCOURSE III will focus on a description of current treatment alternatives, and on the prospects of improved clinical outcomes with drugs having refined pharmacokinetics and combination products offering superior efficacy.